DOI:
10.1055/s-00050348
Indian Journal of Medical and Paediatric Oncology
LinksClose Window
References
Kim ES, Hirsh V, Mok T, Socinski MA, Gervais R, Wu YL. et al.
Gefitinib versus docetaxel in previously treated non-small-cell lung cancer (INTEREST): A randomised phase III trial.
Lancet 2008;
372: 1809-18
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.